BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
News | 02. 11. 2013
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
